[PDF] Top 20 Progress toward the clinical application of patient specific pluripotent stem cells

... Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exog- enous expression of transcription ...These cells, just like embryonic ... See full document

... of clinical application. Exosomes secreted by stem cells have been demonstrated to show similar therapeutic effects on ischemic ...mesenchymal stem cell-derived exosomes could activate ... See full document

... these cells are not immunogenic, although the expres sion levels of MHC molecules increase during the differentiation of ESCs ...significant progress in the development of hESC­based cell therapies, a major ... See full document

... human pluripotent stem cell generation Xeno-free culture reagents for human PS cell mainte- nance are now being applied for the generation of clinically relevant, xeno-free human ES and iPS cell lines ...PS ... See full document

... allow patient-derived organoids to serve as a preclinical platform to bridge the translational gap between animal models and human clinical ...using patient-derived brain organoids have already ... See full document

... pre-clinical stem cell therapies due to their physiological and morphological similarity to humans [28, 29], but they also may greatly benefit from pluripotency in vitro to the generation of genetically su- ... See full document

... the cells are excellent prerequisites to model diseases in ...hiPS cells is currently ...The clinical manifes- tation varies from neonatal icterus and hepatospleno- megaly in early childhood, ... See full document

... of cells that could be used in Parkinson’s disease therapy require suitable animal models in which efficacy and safety can be thoroughly ...testing, clinical trials can begin, but most workers in the field ... See full document

... conclusion, stem cells (both normal and cancerous) are a valuable tool in the drug discovery ...tumorigenic stem cell behavior (Figure 4). Although the direct clinical applications of human ... See full document

... its clinical impact is limited by shortage of suitable donor lungs and transplant ...in stem cell research have attracted a lot of interest to developing reliable means to regenerate injured/diseased ... See full document

... [1]. Clinical symptoms typically appear when 60% to 80% of the estimated half a million DA neurons in the substantia nigra are lost ...the patient population and their long-term benefi t is ... See full document

... The extracellular matrix network of cardiac myocytes remodels its composition during development [123]. While fibronectin dominates during development as well as during pathological remodeling [124-126], collagen becomes ... See full document

... inhibitor clinical trials may be an inter- esting test for this hypothesis in vivo ...these cells is directly relevant to advanced tau/NFT pathology since there is no evidence for tau aggregation nor tau- ... See full document

... embryonic stem cell line H9 ...PP2 cells for 5 ...PP2 cells into IPCs in 7–9 ...insulin-producing cells at the end of the differentiation ... See full document

... into cells of the granulosa phe- notype in addition to epithelial, neural, and mesenchymal cell types, and when stimulated with estrogen, it differ- entiates directly into ...(BM) cells seed the ovaries ... See full document

... recorded SOC currents in GMSLNs differentiated inde- pendently from various HD and WT cell lines. Subse- quently, HD neurons carrying 40–47 glutamine residues reproducibly exhibited 2-fold higher SOC currents rela- tive ... See full document

... After the recent description [77] of mutations in COQ2 gene, encoding one of the enzymes involved in Coenzyme Q10 (CoQ10) biosynthesis, in familial and sporadic cases of MSA, the theme of a mitochondrial role in the ... See full document

... Contemporary healthcare delivery methods will be implemented for regenerative therapy and it will strongly differ from that of traditional healthcare delivery. The National Institute of Health examined business models ... See full document

... cancer cells after ...breast cells results in transformation of cells with overexpressed telomerase and down-regulated ...transformed cells in nude mice generated breast carcinomas with ... See full document

... new stem cell–derived therapy portfolio to the regulatory agencies for inde- pendent review and ...of stem cell therapies in their respective ...earlier, stem cell–based products are considered ... See full document